Cite
Inhibition of PRMT5 attenuates cerebral ischemia/reperfusion–Induced inflammation and pyroptosis through suppression of NF–κB/NLRP3 axis.
MLA
Wu, Xiang, et al. “Inhibition of PRMT5 Attenuates Cerebral Ischemia/Reperfusion–Induced Inflammation and Pyroptosis through Suppression of NF–κB/NLRP3 Axis.” Neuroscience Letters, vol. 776, Apr. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.neulet.2022.136576.
APA
Wu, X., Wang, B., Li, J., Yang, Z., Zhou, Y., Ma, X., Kou, Z., Jiang, L., & Song, J. (2022). Inhibition of PRMT5 attenuates cerebral ischemia/reperfusion–Induced inflammation and pyroptosis through suppression of NF–κB/NLRP3 axis. Neuroscience Letters, 776, N.PAG. https://doi.org/10.1016/j.neulet.2022.136576
Chicago
Wu, Xiang, Bo Wang, Jiaxi Li, Zhongbo Yang, Yunfei Zhou, Xudong Ma, Zhiyan Kou, Liangchao Jiang, and Jinning Song. 2022. “Inhibition of PRMT5 Attenuates Cerebral Ischemia/Reperfusion–Induced Inflammation and Pyroptosis through Suppression of NF–κB/NLRP3 Axis.” Neuroscience Letters 776 (April): N.PAG. doi:10.1016/j.neulet.2022.136576.